Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1
- PMID: 16823458
- DOI: 10.1038/sj.eye.6702495
Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1
Abstract
Purpose: This retrospective study aims to elucidate the role of angiogenesis in the pathogenesis of pterygium. We evaluated microvessel density (MVD), and expression of vascular endothelial growth factor (VEGF) and thrombospondin-1 (TSP-1).
Methods: Fifty-two surgically excised pterygia and seven normal conjunctivae were immunohistochemically studied applying the streptavidin-biotin method in paraffin-embedded tissue sections. Monoclonal antibodies were targeted against CD31, VEGF, and TSP-1 proteins.
Results: Pterygium presented with statistically significant higher average count of microvessels compared to normal conjunctivae (17.97+/-8.5 vs5.72+/-5 per high power field, P=0.001). In 24/52 (46.2%) cases of pterygium, high expression levels for VEGF were demonstrated, whereas the mean percentage of VEGF-positive epithelial cells was 58.03%. Furthermore, normal conjunctival presented statistically significant higher expression levels for VEGF in epithelial cells (83.14+/-36.08 vs58.03+/-31.23%, P=0.007). On the contrary, the presence of VEGF immunoreactivity in vascular endothelial and stromal cells was significantly higher in pterygium tissues (P<0.0001). Stromal staining for TSP-1 was detected in only 29/52 (55.8%) of the cases and no correlation with normal conjunctivae was found. Finally, statistically significant positive correlation between MVD values and stromal VEGF expression was found (P=0.049).
Conclusion: The angiogenesis-related factors that were studied proved to be highly expressed in pterygium tissue. On the contrary, TSP expression level was low, allowing inducers of angiogenesis to act uninhibited. This phenomenon could provide the pathogenic basis of pterygium formation.
Similar articles
-
Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate.Br J Ophthalmol. 2014 Jun;98(6):796-800. doi: 10.1136/bjophthalmol-2012-301944. Epub 2013 Feb 1. Br J Ophthalmol. 2014. PMID: 23376569
-
The expression of vascular endothelial growth factor in mast cells promotes the neovascularisation of human pterygia.Br J Ophthalmol. 2012 Sep;96(9):1246-51. doi: 10.1136/bjophthalmol-2012-301540. Epub 2012 Jul 11. Br J Ophthalmol. 2012. PMID: 22790437
-
Angiogenesis in pterygium: morphometric and immunohistochemical study.Curr Eye Res. 2002 Jul;25(1):17-22. doi: 10.1076/ceyr.25.1.17.9959. Curr Eye Res. 2002. PMID: 12518239
-
Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):607-15. doi: 10.1177/039463201202500307. Int J Immunopathol Pharmacol. 2012. PMID: 23058011 Review.
-
Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.Semin Ophthalmol. 2009 May-Jun;24(3):130-4. doi: 10.1080/08820530902801106. Semin Ophthalmol. 2009. PMID: 19437347 Review.
Cited by
-
The Role of the Stromal Extracellular Matrix in the Development of Pterygium Pathology: An Update.J Clin Med. 2021 Dec 17;10(24):5930. doi: 10.3390/jcm10245930. J Clin Med. 2021. PMID: 34945227 Free PMC article. Review.
-
A Systematic Review of Tear Vascular Endothelial Growth Factor and External Eye Diseases.Int J Mol Sci. 2024 Jan 23;25(3):1369. doi: 10.3390/ijms25031369. Int J Mol Sci. 2024. PMID: 38338647 Free PMC article.
-
Decreased retinal microvasculature densities in pterygium.Int J Ophthalmol. 2021 Dec 18;14(12):1858-1867. doi: 10.18240/ijo.2021.12.08. eCollection 2021. Int J Ophthalmol. 2021. PMID: 34926200 Free PMC article.
-
Hypoxia-Inducible Factor-Dependent Expression of Angiopoietin-Like 4 by Conjunctival Epithelial Cells Promotes the Angiogenic Phenotype of Pterygia.Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4514-4523. doi: 10.1167/iovs.17-21974. Invest Ophthalmol Vis Sci. 2017. PMID: 28873177 Free PMC article.
-
Ocular microvascular alteration in Sjögren syndrome.Quant Imaging Med Surg. 2022 Feb;12(2):1324-1335. doi: 10.21037/qims-21-234. Quant Imaging Med Surg. 2022. PMID: 35111627 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous